Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2014
06/26/2014WO2014100809A2 Ghrh agonists for the treatment of ischemic disorders
06/26/2014WO2014100779A1 Methods ofr production of platelets from pluripotent stem cells and compositions thereof
06/26/2014WO2014100737A1 Methods of treating alzheimer's disease
06/26/2014WO2014100578A1 Peptides useful for modulating histone demethylase function
06/26/2014WO2014100503A1 Drug delivery vehicles
06/26/2014WO2014100433A1 Methods for treatment of microcephaly associated autism disorders
06/26/2014WO2014100407A1 Compstatin analogs
06/26/2014WO2014100361A1 Protection from oxidative damage by gene transfer by glutamate cysteine ligase and glutathione synthase
06/26/2014WO2014100019A1 Prophylactic treatment of herpes recurrence
06/26/2014WO2014099850A1 FACTOR IXa 318R/A MUTANT
06/26/2014WO2014099829A1 Uses of bt lipopeptides as therapeutics for obesity and related diseases
06/26/2014WO2014099795A1 Low viscosity, high caloric density oral nutritional composition and related methods
06/26/2014WO2014099577A1 Process for purifying insulin and analogues thereof
06/26/2014WO2014098249A1 Composition having tissue repairing activity and utilization thereof
06/26/2014WO2014098211A1 Tissue regeneration accelerator
06/26/2014WO2014098088A1 Antifungal agent
06/26/2014WO2014098012A1 Method for activating helper t cell
06/26/2014WO2014097978A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF DISEASE INVOLVING ABNORMAL ACCUMULATION OF AMYLOID β PROTEIN
06/26/2014WO2014097178A1 Antimicrobial compounds, their synthesis and applications thereof
06/26/2014WO2014097123A1 Composition for topical use comprising lactoferrin.
06/26/2014WO2014096985A2 A stable aqueous composition comprising human insulin or an analogue or derivative thereof
06/26/2014WO2014096440A2 Composition
06/26/2014WO2014096437A1 Alternative oxidase (aox) prevents smoking-associated lung damage
06/26/2014WO2014096402A1 Enzyme having a nmda receptor antagonist activity and/or an anticholinergic activity
06/26/2014WO2014096384A1 Use of antisecretory factor (af) in glioblastoma treatment
06/26/2014WO2014096150A1 Dual glp1/gip or trigonal glp1/gip/glucagon agonists
06/26/2014WO2014096149A1 Exendin-4 Derivatives
06/26/2014WO2014096148A1 Functionalized exendin-4 derivatives
06/26/2014WO2014096145A1 Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
06/26/2014WO2014096087A1 Methods and pharmaceutical compositions for prevention of aging-related lesions
06/26/2014WO2014096032A1 Gm-csf for treatment of chronic sinusitis
06/26/2014WO2014094840A1 Use of pidotimod to treat psoriasis
06/26/2014WO2014094839A1 Use of pidotimod to treat atopic dermatitis
06/26/2014WO2014094579A1 Recombinant protein
06/26/2014WO2014094546A1 Use of fusion protein
06/26/2014WO2014094353A1 Maytansinoid derivatives
06/26/2014WO2014094230A1 Application of sp peptide or derivative thereof in preparing drugs for preventing or treating asthma
06/26/2014WO2014094122A1 Treatment of cd47+ disease cells with sirp alpha-fc fusions
06/26/2014WO2014094043A1 Methods of generating cells with multilineage potential
06/26/2014WO2014071211A3 Molecules, compositions and methods to treat organ scarring
06/26/2014WO2014070965A3 Somatostatin analogs and dimers thereof
06/26/2014WO2014068327A3 Agents for the prevention and/or treatment of central nervous system damage
06/26/2014WO2014066507A9 Allogeneic autophagosome-enriched composition for the treatment of disease
06/26/2014WO2014040074A3 Compositions and methods for treating cutaneous scarring
06/26/2014WO2013189606A3 Interval therapy for the treatment of loss of eyesight in humans with glaucoma and other degenerative eye diseases
06/26/2014WO2013082563A8 Protein inhibitors to complement and vegf pathways and methods of use thereof
06/26/2014WO2012162628A3 Lipopeptide inhibitors of ras oncoproteins
06/26/2014US20140182017 Molecular markers of plant embryogenesis
06/26/2014US20140179771 Modified polynucleotides for treating dolichyl-phosphate (udp-n-acetylglucosamine) n-acetylglucosaminephosphotransferase 1 (glcnac-1-p transferase) protein deficiency
06/26/2014US20140179621 Methods for Treating or Preventing Ophthalmological Diseases
06/26/2014US20140179618 Novel cancer therapies and methods
06/26/2014US20140179617 Cytotoxic Factors For Modulating Cell Death
06/26/2014US20140179616 Peptides that stimulate subcutaneous adipogenesis
06/26/2014US20140179615 Glutathione and Acetaminophen Composition and Preparation Method Thereof
06/26/2014US20140179613 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF
06/26/2014US20140179611 Tribonectins
06/26/2014US20140179608 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphatase and SRC
06/26/2014US20140179607 Treatments for Gastrointestinal Disorders
06/26/2014US20140179604 Ghrh agonists for the treatment of ischemic disorders
06/26/2014US20140179601 Fgf-9 and its use relating to blood vessels
06/26/2014US20140179600 Stable formulations for parenteral injection of peptide drugs
06/26/2014US20140179599 Stable formulations for parenteral injection of peptide drugs
06/26/2014US20140179597 Method for the treatment and prevention of Alzheimer's disease and central nervous system dysfunction
06/26/2014US20140179596 Albumin fusion proteins
06/26/2014US20140179595 Apolipoprotein e polypeptides and their use
06/26/2014US20140179594 Streptococcus bacteriophage lysins for treatment of gram positive bacteria in companion animals and livestock
06/26/2014US20140178986 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/26/2014US20140178507 Weight management composition
06/26/2014US20140178476 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
06/26/2014US20140178474 Selective local inhibition of tnfr1-mediated functions at the site of antigen/allergen presentation
06/26/2014US20140178472 Methods of Regulating Glucose Metabolism, and Reagents Related Thereto
06/26/2014US20140178453 Devices and methods for the regeneration of bony defects
06/26/2014US20140178451 Activators of cxcr3 for the treatment of angiopathies of the eye
06/26/2014US20140178420 Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
06/26/2014US20140178407 Methods and Compositions for Treating Conditions of the Eye
06/26/2014US20140178406 Use of goat serum for veterinary treatment
06/26/2014US20140178404 Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis
06/26/2014US20140178392 Nogo Receptor-Mediated Blockade of Axonal Growth
06/26/2014US20140178357 Stabilized liquid and lyophilized adamts13 formulations
06/26/2014US20140178356 Stabilised Solid Compositions of Factor VII Polypeptides
06/26/2014US20140178355 Compositions and Methods for Treating Celiac Sprue Disease
06/26/2014US20140178353 Bacterial anti-phage defense systems
06/26/2014US20140178352 Peptide inhibitors of protein kinase c
06/26/2014US20140178351 Compositions and methods relating to argininosucccinate synthetase
06/26/2014US20140178340 Cancer combination therapy and recombinant vectors
06/26/2014US20140178339 Insulin-like growth factor binding protein 7 for treatment of cancer
06/26/2014US20140178336 Antiviral compounds
06/26/2014US20140178334 Methods and compositions for liquidation of tumors
06/26/2014US20140178333 Homogenous preparations of il-28 and il-29
06/26/2014US20140178307 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression
06/26/2014US20140178300 Theranostic imaging agents and methods of use
06/26/2014US20140178295 Method for Treating Psoriasis By Administering An Anti-IL-12 Antibody
06/26/2014DE102012024749A1 Tumorprävention und -therapie durch Induktion einer Tumorseneszenz Tumor prevention and therapy by inducing Tumorseneszenz
06/25/2014EP2745846A1 Drug for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor gc-a agonist and gc-b agonist
06/25/2014EP2745842A2 Anti-cancer composition comprising wnt decoy receptors
06/25/2014EP2745709A1 Nutritional compositions with reduced beta-casein a1 and related methods
06/25/2014EP2744831A2 Transferrin-tumstatin fusion protein and methods for producing and using the same
06/25/2014EP2744821A1 Inhibitors against endosomal/lysosomal enzymes
06/25/2014EP2744510A1 N-glycosylated insulin analogues
06/25/2014EP2744509A1 Use of interferon beta for the treatment of alopecia areata
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 3163